MD Longevity

MD Longevity operates as a San Francisco-based anti-aging and regenerative medicine practice under the medical direction of Ann J. Peters, MD. The clinic focuses on evidence-based interventions that address age-related decline through hormone optimization, peptide therapeutics, and metabolic restoration protocols. Dr. Peters structures treatment plans around comprehensive laboratory analysis, including advanced biomarker panels that assess hormonal status, inflammatory markers, metabolic function, and cellular aging indicators. Patients receive in-person consultations at the San Francisco location, where initial evaluations typically include detailed health histories, physical examinations, and discussion of treatment goals specific to longevity and functional optimization.

MD Longevity offers a range of peptide therapy options tailored to individual patient needs. Treatment protocols are customized based on health goals, lab work, and medical history, with options for hormone optimization, metabolic health, tissue repair, and performance enhancement.

Dr. Ann J. Peters brings her medical training to the practice of age management medicine, applying clinical judgment to the selection and monitoring of regenerative therapies. Her approach emphasizes bioidentical hormone replacement therapy for both men and women experiencing symptoms of hormonal decline, including testosterone deficiency, estrogen/progesterone imbalances, thyroid dysfunction, and adrenal insufficiency. Hormone protocols are individualized based on symptom presentation and laboratory values, with ongoing monitoring to maintain physiologic ranges and minimize adverse effects. The clinic uses bioidentical formulations that match the molecular structure of endogenous hormones, prescribed in forms that include transdermal creams, subcutaneous pellets, and injectable preparations depending on patient preference and clinical indication.

Patients at MD Longevity undergo structured follow-up schedules that include repeat laboratory testing at intervals determined by the specific therapies employed. Initial peptide therapy cycles typically run 8-12 weeks with assessment points to evaluate clinical response and adjust dosing. Hormone replacement protocols require more frequent monitoring during the first three to six months, then transition to quarterly or biannual assessments once stable therapeutic levels are achieved. The clinic provides education on administration techniques for self-injectable peptides and monitors for potential side effects or contraindications that may emerge during treatment. Office visits include review of subjective improvements in energy, body composition, cognitive function, sleep quality, and other parameters relevant to age-related decline.

MD Longevity maintains an in-person consultation model that serves patients throughout the San Francisco Bay Area. The practice does not currently offer telehealth services, requiring patients to visit the San Francisco office for initial evaluations and follow-up appointments. This in-person approach allows Dr. Peters to conduct physical examinations, assess body composition changes, and provide hands-on instruction for therapy administration. The clinic's 5.0-star rating from patient reviews reflects satisfaction with the personalized attention and clinical outcomes achieved through its regenerative medicine protocols. MD Longevity accepts patients seeking alternatives to conventional approaches for age-related symptoms, metabolic dysfunction, hormonal imbalances, and performance optimization, with treatment plans designed to address root causes rather than symptom suppression alone.